L,-In the 5-year period from 1978 to 1983, 1076 patients with ruptured intracranial aneurysms were admitted to the six neurosurgical departments in Denmark and were entered in a prospective consecutive study conducted by the Danish Aneurysm Study Group. The patients were followed with 3-month and 2-year examinations or to death. A total of 133 patients suffered at least one rebleed after their initial hemorrhage during their first stay in the neurosurgical department: these patients had a mortality rate of 80% compared to 41% for patients without a rebleed (p < 0.0001). During the first 2 weeks after the initial insult, 102 rebleeds were registered. The daily rate of rebleeds during these 2 weeks, calculated using a life-table method, varied from 0.2% to 2.1%. The rebleed rate during the first 24 hours (Day 0) was 0.8%, and the maximum risk of rebleeding was observed between Day 4 and Day 9. Significantly fewer rebleeds were reported in patients with good clinical grades (Grades 1 to 3, Hunt Grades I and II) compared to those with poor clinical grades (Grades 4 to 9, Hunt Grades III to V: p < 0.001).
S
UBARACHNOID hemorrhage (SAH) from ruptured intracranial aneurysms is a serious disease with high rates of mortality (50% to 60%) and morbidity (20% to 30%). 4"6' 8"9"13"15"16"18"20"22"23"26' 3' 1 Patients suffering, from an aneurysmal rerupture have an even poorer prognosis, with a mortality rate of 70% to 90%. ~5233~ '34 The primary purpose of neurosurgical treatment of ruptured aneurysms is to prevent a rebleed, and knowledge of the daily risk of rebleeding is essential.
It has been reported that the highest risk of rebleeding occurs in the second part of the 1st week and in the beginning of the 2nd week after the initial aneurysmal rupture. 4"14"1v'18"27"31 However, in the 1983 report from the Cooperative Aneurysm Study by Kassell and Torner, 1~ including 2265 patients, the rate of rebleeding was 4.1% within the first 24 hours. During recent years, the optimal time for aneurvsm surgery has been eagerly The report of a 4% rate of rebleeding within the first 24 hours has provided a strong argument for early surgery. Because of the different reports concerning the peak time of aneurysmal rerupture, we have tried to elucidate the problem further using data obtained from the Danish Aneurysm Study] 3
Clinical Material and Methods
A prospective consecutive study during the 5-year period from April 1, 1978 , to March 31, 1983 , included all patients with ruptured intracranial aneurysms admitted in the six Danish neurosurgical departments. There were 1076 patients; 674 (62%) were women, with a median age of 49 years (range 14 to 77 years), and 402 (38%) were men, with a median age of 48 years (range 12 to 76 years). A comprehensive clinical examination of each patient was conducted on admission, and the results were assessed using a modified Hunt classification 5 with 10 grades (Table 1) . Rebleeding was suspected when there was a sudden deterioration in the patient's clinical status resembling a classical SAH. Every, episode of rerupture was recorded, and in 84% of these cases the hemorrhage was verified by cerebrospinal fluid (CSF) analysis, by computerized tomography (CT), by intraoperative observations, or at autopsy. All of the patients were followed with 3-month and 2-year examinations or until death.
The interval between the initial SAH and admission to the neurosurgical department is presented in Table  2 . More than 70% of the patients were admitted within 2 days of their initial SAH. The patients were treated 
Results
During the patients' initial hospital stay a total of 133 first rebleeds were recorded. The mortality and morbidity data for these patients at the 2-year followup review are shown in Table 3 , and the outcome at the 2-year follow-up review of the 943 patients without a rebleed is indicated in Table 4 . The mortality rate in patients with and without aneurysmal rerupture was 80% and 41%, respectively; this difference was significant (p < 0.0001). A corresponding difference in the occurrence of a normal outcome was seen: 8% in patients with a rebleed and 30% in patients without a rebleed.
A significantly lower rate of rerupture was seen in the group of 205 patients who received EACA compared to those who did not receive this treatment (7% and 13%, respectively). However, the overall morbidity and mortality rates at the 2-year follow-up review did not differ significantly between these two groups.
During the first 2 weeks after the initial SAH, a total of 102 rebleeds were recorded and the diagnosis was verified by CT scan (36%), CSF investigations (34%), autopsies (10%), or intraoperative observations (4%). In the remaining 16% of cases, the diagnosis was based on a classical clinical picture of a new SAH. The daily number of rebleeds based on clinical observations alone and the total daily number during the 2-week period are indicated in Table 5 . The daily and cumulative rates ofaneurysmal rerupture in this period were calculated, using the life-table method 2 to adjust for interval to operation and interval to death or discharge of nonoperated survivors (Fig. 1) . The maximum daily rate of rebleeds was 2.1% observed on Day 9. The rate of rebleeding was 0.8 % within the first 24 hours and varied from 0.2% to 1.0% daily during the first 4 days. From Days 5 to 12 the rate varied from 1.2% to 2.1%, and on Days 13 and 14 a decrease of rebleeding was observed. A significantly fewer number of rebleeds among patients in a good clinical condition (Grades 1 to 3) compared to patients in a poorer clinical status (Grades 4 to 9) was observed (p < 0.001, Fig. 1 ). Within 2 weeks of the initial SAH the cumulative rate of rebleeding for the total series was 16.8%: 11.6% for patients in clinical Grades 1 to 3 and 21.6% for those in clinical Grades 4 to 9 (p < 0.001). The rate of rebleeding within the first * Day 0 = day of initial subarachnoid hemorrhage (SAH).
Risk of aneurysmal rebleeding
2 weeks was 8.3% in patients who received EACA and 20.0% in patients without antifibrinolytic treatment. This difference is significant (p < 0.001).
Discussion
In the present study the cumulative rate of rebleeding in 1076 patients was 16.8% within the first 2 weeks after the initial SAH. This rate is a little lower than found by others. Jane, et al., 6 found an aneurysmal rerupture rate of 20% within the first 14 days, and Kassell and Torner ~~ reported a 19% rate for the first 2 weeks (14.1% in patients who received antifibrinolytic therapy and 26.5% in patients without antifibrinolytic treatment); however, a distinction between patients in good and poor clinical condition was not mentioned. In our study a significantly higher rate of rebleeding was demonstrated in patients in poor clinical grades compared to those in good clinical grades. This observation is in agreement with the findings of other authors/'~5 The differences between our study and others 6~~ in the cumulative rate of rebleeding can be explained by variations in composition of the series. On the other hand, in this and other series L~~176 more than twice the number of patients reported by Kassell and Torner ~~ received antifibrinolytic treatment, which has led to a lower rate of rebleeding. However, as mentioned before, this lower rate of rerupture does not necessarily mean lower morbidity and mortality rates.
Kassell and Torner 1~ found a peak in the daily rate of rebleeding during the first 24 hours (4.1%); while we and others 6'4'7 found a rather low risk of rebleeding within the first 24 hours compared to the mean daily risk of rebleeding during the first 2 weeks after the initial hemorrhage. Kassell and Torner also reported a nearly constant rate of rebleeding after the first 24 hours, which is in agreement with the findings of Jane, et al., 6 but differs from our study and others? 4' L7"27"31 in which the highest risk of repeat hemorrhage was found at the end of the 1 st week and the beginning of the 2nd week. In the report of Suzuki and H o r i 27 this peak was only seen in patients who did not lose consciousness in connection with the initial SAH.
The above-mentioned differences do not vary substantially, except for the very different rate of rebleeding during the first 24 hours between this study and that of Kassell and Torner. ~0 An explanation for this difference is not obvious, but the composition of the two series differs in some ways. The 2265 patients in Kassell and Torner's group were derived from 60 neurosurgical departments in 16 countries. The patients entered in the Danish Aneurysm Study reported here were collected from six neurosurgical departments in a well-defined area (the Kingdom of Denmark), with a well-defined population. Furthermore, the methods of referral and treatment of patients within the six Danish departments are very similar.
If early surgery does not influence the patients' course other than in preventing rerupture, this protocol must be preferred. The benefits of this strategy seem to be documented for patients in good clinical condition in the Cooperative Aneurysm Study (NF Kassell, personal communication, July, 1985) . These findings are in agreement with the results of the Danish Aneurysm Study, 23 while surgery in patients in poor clinical condition should be postponed for some days.
